AVAVA™ Announces the Launch of MIRIA™ at ASLMS 2024 the Energy-Based Medicine & Science Conference
AVAVA™, an innovative aesthetics company focused on becoming a portal to the future of skin vitality, today announces the official launch of MIRIA™ by AVAVA. In addition, through an exclusive distribution partnership with Jeisys, MIRIA will be available in Korea…
Genetics of Nearby Healthy Tissue May Help Catch Lung Cancer’s Return
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its…
Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study
Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a machine-learning tool developed to predict the risk of chronic kidney disease (CKD) progression at all stages of the disease. Using data from a diverse population…
Hope for Prostate Cancer Patients: Avenda Health’s Unfold AI Enables Precise Cancer Mapping
There is newfound hope for prostate cancer patients as Avenda Health introduces Unfold AI, an innovative technology that employs machine learning to accurately map the extent of prostate cancer. Unfold AI’s ground-breaking 3D visualization technique ensures physicians can formulate personalized…
